Company Profile
Neuronetics Stock Price, News & Analysis
- Ticker:
- STIM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.25 USD (-4.26%)
Close
Last updated: August 6, 2026
109M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, STIM closed down 4.26% at $2.25. No new same-company headline was identified in the current news window.
Company overview
Neurohealth Technology and Care Delivery
Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy.
NeuroStar Advanced Therapy
NeuroStar uses transcranial magnetic stimulation to treat major depressive disorder without surgery or systemic medication. The platform is supported by a large clinical dataset and is sold to healthcare providers together with recurring treatment-session consumables and services.
Greenbrook Clinic Network
Through Greenbrook treatment centers, Neuronetics directly provides NeuroStar therapy and SPRAVATO for treatment-resistant depression. The integrated model gives the company exposure to both medical-device utilization and the economics of operating behavioral-health treatment sites.
Future catalysts
Neuronetics’ catalysts are neurostimulation adoption, payer coverage, and continued growth in mental-health treatment use. The company needs broader procedure adoption to keep the story moving.
Recent news
- 01
Neuronetics and Jorey Chernett Announce Shared Vision
Source: Neuronetics
- 02
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Source: Neuronetics
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Neuronetics (STIM)?
Neuronetics (STIM) most recently closed at 2.25 USD, a -4.26% move versus the previous session.
What is the market cap of Neuronetics (STIM)?
Neuronetics currently has a market capitalization of 109M USD on BioPharmSignal.
What does Neuronetics do?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses transcranial magnetic...
On which exchange is STIM stock listed?
Neuronetics (STIM) is associated with NASDAQ, United States, Biopharma.
What is Neurohealth?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders.
Which conditions is Neuronetics targeting with Neurohealth?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses transcranial magnetic...
How does Neuronetics describe recent progress with Neurohealth?
Neuronetics’ catalysts are neurostimulation adoption, payer coverage, and continued growth in mental-health treatment use. The company needs broader procedure adoption to keep the story moving.
What is Technology?
Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders.